WO2002092166A1 - Methode et appareil pour traiter le cancer au moyen d'un champ magnetique - Google Patents
Methode et appareil pour traiter le cancer au moyen d'un champ magnetique Download PDFInfo
- Publication number
- WO2002092166A1 WO2002092166A1 PCT/CN2001/001474 CN0101474W WO02092166A1 WO 2002092166 A1 WO2002092166 A1 WO 2002092166A1 CN 0101474 W CN0101474 W CN 0101474W WO 02092166 A1 WO02092166 A1 WO 02092166A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- magnetic field
- treating cancer
- human body
- body fluid
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
Definitions
- the present invention relates to a method for treating cancer, in particular to a method for treating cancer using a magnetic field, and the present invention also relates to a device for the treatment method. Background technique
- An object of the present invention is to provide a method for treating cancer using a magnetic field. It is another object of the present invention to provide a device for use in the method.
- a cancer cell is an immature cell with a loose membrane structure, which allows cancer cells to migrate away from the tumor. It turns out that the magnetized liquid can erode the cell membranes of cancer cells that come into contact with it, making them thin and brittle. At this time, if a magnetic field is applied to the cancer cells, tidal phenomena will occur in the cytoplasm of cancer cells, and the cytoplasm will continuously impact the cell membrane. And eventually break through the cell membrane, leading to the death of cancer cells. Therefore, the present invention uses this principle to magnetize body fluids of the human body, and then uses a magnetic field to treat the body with the magnetized body fluids to kill cancer cells in the human body and cure the cancer.
- the body fluids of the human body need to be magnetized first.
- the magnetization of body fluids cannot be performed directly in the human body. This is because when a liquid is magnetized, a large amount of oxygen is absorbed from the air under the action of a liquid magnetic field, and the closed environment of the human body meets the need for a large amount of oxygen in the body fluids, Body fluids cannot be directly magnetized in the human body.
- the method for magnetizing human body fluid according to the present invention is that the human body continuously The magnetized water is taken in place to form the metabolism of the magnetized water in the human body, and the body fluids in the human body are metabolized into magnetized body fluids. Human body fluid magnetization usually takes 2-5 days. During this period, any fluid ingested by the human body is replaced with magnetized water.
- a vertical magnetic field with horizontal magnetic field lines should be used instead of a circular magnetic field line.
- the magnetic field lines are strong, the magnetic field lines are nearly parallel to the greatest extent, and there is no magnetic field line vortex, which prevents the magnetic field line vortex from affecting the human heart and causing arrhythmia, palpitations, and insomnia.
- the magnetic field should also be kept still, and the human body should be moved in the magnetic field to prevent the magnetic field lines from vortexing when the magnetic field moves.
- the magnetic field strength of the vertical magnetic field is controlled between 0.1 to 0.4 Gauss.
- cancer cells in a magnetized body fluid atmosphere can react in a magnetic field for 5 minutes, and reach the peak in 1 hour. When the time exceeds 1 hour, the effect efficiency will gradually decrease. Therefore, the duration of each magnetic field treatment should be 10-60 minutes, and the interval between the two treatments should be at least 12 hours.
- the present invention provides a device dedicated to treating cancer using magnetic fields.
- the device of the present invention is composed of a seat, a base, and a bracket.
- the seat is connected to the center of the base by a vertical raising and lowering rod installed below the seat.
- Two brackets are fixedly installed on the front and rear seats of the seat, and the bracket is horizontally installed on the base.
- the magnets are placed on the front and rear support plates, respectively.
- the invention uses a magnetic field to treat cancer, and the treatment process is easy and painless.
- the patient does not need to undergo painful treatment process, and the cancer is cured normally.
- the control method is adopted, and the interval treatment is used to prevent the cancer state from deteriorating to prolong life.
- the magnetic field has the effect of enhancing the vitality of normal somatic cells, it can also enhance the physical performance of the body while treating cancer, without any side effects during the treatment process. And can quickly kill cancer Cells, it works quickly.
- the seat can be vertically moved up and down, and the magnet can also be adjusted horizontally back and forth.
- the treatment it can be adjusted so that any part of the human body is within the range of the vertical magnetic field. There is no dead angle.
- the operation is very simple and convenient. The advantages of using magnetic fields to treat cancer come into play.
- FIG. 1 is a schematic structural diagram of a device for treating cancer using a magnetic field according to the present invention. Specific application examples of the present invention
- the treatment method is to make the patient continuously drink magnetized water, and the food that the patient eats is also made of magnetized water. After 2 to 5 days of preparation, through continuous metabolism, the magnetized water enters the human body to form a magnetized body fluid, replacing the human.
- the original body fluids in the body meet the internal conditions for killing cancer cells with magnetic fields.
- FIG. 1 A device for treating cancer by using a magnetic field is shown in FIG. 1.
- a vertical lifting rod 5 is installed in the center of the horizontal base 6, and the seat 4 is mounted on the vertical lifting rod 5, and can be vertically raised and lowered along with it.
- a bracket 2 is fixed on each of the positions of the base 6 at the front and rear of the seat 4, and a supporting plate 3 is horizontally installed on the bracket 2. The supporting plate 3 can be moved forward and backward in the horizontal direction.
- Two magnets with opposite magnetic poles are respectively placed on the two supporting plates 3, and a vertical magnetic field with horizontal magnetic lines of force can be formed between the two magnets.
- the magnetic field strength of the magnet is from 0.1 to 0.4 Gauss.
- the patient When in use, the patient sits on the seat, adjusts the vertical lift lever so that the magnet is located at the part of the patient to be treated, and then horizontally adjusts the support plate so that the front and rear magnets are properly positioned from the patient's body, and the treatment can be started.
- Patients should be appropriately replenished with magnetized water during treatment.
- the vertical lifting rod can be adjusted to change the part of the body that the magnet acts on. The duration of each treatment is 60 minutes. After the treatment is over, you should rest for 12 hours before proceeding to the next treatment. Magnetized water should also be constantly replenished during breaks to maintain
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01116053 CN1320464A (zh) | 2001-05-14 | 2001-05-14 | 利用磁场治疗癌症的方法及装置 |
CN01116053.5 | 2001-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002092166A1 true WO2002092166A1 (fr) | 2002-11-21 |
Family
ID=4662360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2001/001474 WO2002092166A1 (fr) | 2001-05-14 | 2001-10-10 | Methode et appareil pour traiter le cancer au moyen d'un champ magnetique |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1320464A (zh) |
WO (1) | WO2002092166A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2255831B1 (es) * | 2004-08-06 | 2007-07-16 | Daniel Serrano Gil | Disposicion y metodo para destruccion selectiva de acumulaciones celulares de gran actividad con proliferacion celular incontrolada. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1053555A (zh) * | 1990-01-16 | 1991-08-07 | 余少文 | 强磁场治癌装置 |
US5067952A (en) * | 1990-04-02 | 1991-11-26 | Gudov Vasily F | Method and apparatus for treating malignant tumors by local hyperpyrexia |
US5667469A (en) * | 1993-10-08 | 1997-09-16 | Zhang; Xiaoyun | Strong magnetism therapeutic apparatus with permanent-magnets rotating at low frequency |
-
2001
- 2001-05-14 CN CN 01116053 patent/CN1320464A/zh active Pending
- 2001-10-10 WO PCT/CN2001/001474 patent/WO2002092166A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1053555A (zh) * | 1990-01-16 | 1991-08-07 | 余少文 | 强磁场治癌装置 |
US5067952A (en) * | 1990-04-02 | 1991-11-26 | Gudov Vasily F | Method and apparatus for treating malignant tumors by local hyperpyrexia |
US5667469A (en) * | 1993-10-08 | 1997-09-16 | Zhang; Xiaoyun | Strong magnetism therapeutic apparatus with permanent-magnets rotating at low frequency |
Also Published As
Publication number | Publication date |
---|---|
CN1320464A (zh) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2141855C1 (ru) | Магнитотерапия и физиотерапевтическое устройство со сканирующим магнитным полем | |
Yang et al. | Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma | |
Salford et al. | Experimental studies of brain tumour development during exposure to continuous and pulsed 915 MHz radiofrequency radiation | |
JP2010516259A5 (zh) | ||
WO1995010325A1 (fr) | Dispositif de magnetotherapie intense a aimant permanent rotatif basse frequence | |
Niederkorn | Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice. | |
Sorenson et al. | The utilization of paramecia by the carnivorous plant Utricularia gibba | |
WO2002092166A1 (fr) | Methode et appareil pour traiter le cancer au moyen d'un champ magnetique | |
WO2011113140A1 (en) | Magnetic apparatus used for drug delivery | |
CA2194485A1 (en) | Endothelial lining effects and treatment of vasospastic disorders | |
Nishiguchi et al. | Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors | |
CN104042628B (zh) | 氢氧化铝在制备治疗肝癌药物中的应用 | |
CN206007805U (zh) | 一种多磁头旋磁治疗机 | |
EP2470213A1 (en) | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast | |
Zhao et al. | Hepatocyte regeneration after partial liver irradiation in rats | |
CN202366331U (zh) | 经颅磁刺激装置 | |
Nakamura et al. | Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines | |
CN213607864U (zh) | 一种医学用针灸床 | |
Ohara et al. | Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator | |
CN1053555A (zh) | 强磁场治癌装置 | |
Tazawa et al. | A Study of Inductive Heating for Cancer with Use of Dextran Magnetite (II) Effect for Various Cancer Cells by Intracellular Hyperthermia | |
CN211767273U (zh) | 一种稀土钕铁硼柱形磁疗推筋弓及其存放箱 | |
CN201299907Y (zh) | 内科慢性病理疗装置 | |
Wang et al. | Traditional Chinese Medicine Cupping and Health | |
CN211326756U (zh) | 一种生殖科辅助治疗设备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |